findmyKOL

Hiral Shah, MD

Basic profile

Columbia University Irving Medical Center

ORCIDNPI
RegionNew York, NY · NortheastSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Hiral Shah is a Neurology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 46 publications with 1,015 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
46publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,015citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

710 W 168th St
3rd Floor
New York, NY 100323726

Telephone

212-305-5558

Provider last certified this registry record 18 Nov 2022.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    95.4%
    Aromatic Amino Acid Decarboxylation Inhibitor21.4%
    Carbidopa-Levodopa64%Carbidopa-Levodopa Er36%
    Part D100 patients
    Cholinesterase Inhibitor16.1%
    Donepezil Hcl69%Rivastigmine31%
    Part D<11 patients

    + 20 more classes in this area

  • Musculoskeletal

    3.2%
    Central alpha-2 Adrenergic Agonist1.6%
    Tizanidine Hcl100%
    Part D13 patients
    gamma-Aminobutyric Acid-ergic Agonist0.9%
    Baclofen100%
    Part D<11 patients

    + 1 more class in this area

  • Cardiovascular

    1.4%
    Beta blocker0.7%
    Propranolol Hcl Er100%
    Part D<11 patients
    Statin0.7%
    Atorvastatin Calcium100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”